Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MIDA Biotech
Leiden, South Holland, Netherlands
- Ownership
- Private
- Development stage
- Other
01
Overview
MIDA Biotech is developing processes for cost-effective, rapid, and standardized autologous iPSC manufacturing using microfluidic and AI-based technologies, with focus on regenerative medicine and personalized cell therapies. The company is at the R&D stage, supported by a €4 million European Innovation Council Pathfinder Challenge grant in collaboration with Leiden University and others. No clinical trial data yet announced.
- Therapeutic areas
- OncologyNeurologyRheumatology
- Modalities
- Induced pluripotent stem cell derived therapyCell therapy
- Industry
- Biotech
02
Partnerships
OrgenesisLeiden University
Beyond the preview
Go deeper on MIDA Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MIDA Biotech.